Mr. Speaker, one particular point I would like to hit on is that Canadians understand the inability to afford medication. The trans-Pacific partnership would extend the patents, which would mean that it would cost Canadians more money to take the medication necessary for a pathway to health. That alone is egregious in the trans-Pacific partnership, and people understand the impact of that on their lives.
In the House of Commons on September 19th, 2016. See this statement in context.